WEDNESDAY, Oct. 22, 2025 (HealthDay News) — The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers containing acetaminophen, calling the request “unsupported by the scientific evidence and legally and procedurally improper.” Kenvue’s response, dated Oct. 17, came afterContinue Reading

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — For the estimated one-third of people with focal epilepsy who don’t respond well to initial medications, new research offers significant reason for optimism.  A study suggests that even those considered “treatment-resistant” may eventually see a substantial reduction in their seizures over time. FocalContinue Reading